UNITED STATES
SECURITIES AND EXCHANGE COMMISSION
Washington, DC 20549
FORM 8-K
CURRENT REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE
SECURITIES EXCHANGE ACT OF 1934
Date of Report (Date of earliest event reported): January 6, 2017
EARTH SCIENCE TECH, INC. |
(Exact Name of Registrant as Specified in its Charter) |
Nevada |
(State or Other Jurisdiction of Incorporation) |
000-55000 | 45-4267181 | |
(Commission
File Number) |
(IRS
Employer Identification No.) |
8000 NW 31st Street, Suite 19 Doral, FL |
33122 | |
(Address of Principal Executive Offices) | (Zip Code) |
(Registrant’s telephone number, including area code): (305) 615-2118
Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2.)
[ ] | Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425) |
[ ] | Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12) |
[ ] | Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b)) |
[ ] | Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c)) |
Item 8.01. Other Events.
Creation of New Wholly Owned Subsidiary
On January 26, 2017, The Registrant formed a new wholly owned subsidiary called Cannabis Therapeutics, Inc.
The purpose of the new subsidiary is to explore synergies in researching and developing new CBD-based nutraceuticals and pharmaceutical compounds based on the Registrant’s International Application (PCT) for its Provisional Patent named “Cannabidiol Compositions Including Mixtures and Uses Thereof” which was filed on October 8th, 2015 in regards to its Cannabis Hemp CBD (Cannabidiol) Oil
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
EARTH SCIENCE TECH, INC. | |
Dated: November 9, 2017 | /s/ Nickolas S. Tabraue |
Nickolas S. Tabraue | |
President and COO |